FDA Abandons Its Defense of the LDT Rule, But is It Signaling an Increase in RUO Scrutiny? June 3, 2025 By Steven J. Gonzalez & Allyson B. Mullen —

https://www.thefdalawblog.com/2025/06/fda-abandons-its-defense-of-the-ldt-rule-but-is-it-signaling-an-increase-in-ruo-scrutiny/?utm_source=rss&utm_medium=rss&utm_campaign=fda-abandons-its-defense-of-the-ldt-rule-but-is-it-signaling-an-increase-in-ruo-scrutiny